Profiles: Page 7
The latest opinion pieces by industry thought leaders
-
Permission granted by Dr. Tania Small
Disrupters: Dr. Tania Small
GSK’s medical oncology head is paving the way for patient-driven drug development and more equitable care.
PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Trishna Bharadia
Disrupters: Trishna Bharadia
As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.
Alexandra Pecci • Sept. 6, 2022 -
Permission granted by Vincent Keunen
Entrepreneurs: Vincent Keunen
With his unique platform, the has built a bridge between patients, physicians and researchers around the world.
Meagan Parrish • Sept. 6, 2022 -
Permission granted by WeiQing Zhou
Entrepreneurs: WeiQing Zhou
The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry.
Meagan Parrish • Sept. 6, 2022 -
Permission granted by Yvonne Greenstreet
Disrupters: Dr. Yvonne Greenstreet
The CEO of Alnylam — a leader in RNAi therapies — has the company at the top of its game scientifically and culturally.
PharmaVoice staff • Sept. 6, 2022 -
Getty Images
Leading the industry’s next potential game-changer in drug discovery
Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.
Alexandra Pecci • Aug. 29, 2022 -
Getty Images
The power of the underdog: A rare disease nonprofit working to help patients win against the odds
Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.
Alexandra Pecci • July 13, 2022 -
Permission granted by SaNOtize/Gilly Regev
From vineyards to antivirals, Gilly Regev brings creative thinking to science
The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.
Alexandra Pecci • June 27, 2022 -
Michael Ciaglo / Stringer via Getty Images
Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching
Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.
Alexandra Pecci • June 14, 2022 -
Getty Images
After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development
The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.
Alexandra Pecci • June 7, 2022 -
Permission granted by Flagship Pioneering/Avak Kahvejian.
Flagship's creative approach to finding the next big idea in biopharma
Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.
Alexandra Pecci • June 1, 2022 -
Permission granted by SpringWorks/Jim Cassidy
Jumping into pharma with big plans at a small company
SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.
Alexandra Pecci • May 17, 2022 -
Permission granted by TauRx
With the shine of amyloid fading, tau is a rising star in Alzheimer's
The tau theory in Alzheimer's is being put to the test with phase 3 trial results due later this month from TauRx Pharmaceuticals.
Michael Gibney • May 11, 2022 -
Getty Images
Breaking new ground: Longhorn's trailblazing effort to develop a universal flu vaccine
After years of success with their diagnostic platform for COVID-19, tuberculosis and the flu, the family funded company is shifting priorities back to the vaccine market.
Taren Grom and Karissa Waddick • May 4, 2022 -
Permission granted by Nelson Ambrogio.
Bayer executive makes strides toward a finish line for rare cancers
Bayer's SVP and general manager of U.S. oncology completed the Boston Marathon to honor his brother and bring attention to rare cancers.
Alexandra Pecci • May 3, 2022 -
Getty Images
From cancer survivor to clinical trial innovator
How Alicia Staley is using her insights as a three-time cancer survivor to drive clinical trial improvements at Medidata.
Kelly Bilodeau • May 3, 2022 -
Permission granted by Laura Randa.
Laura Randa's aim to break down mental healthcare barriers for disabled patients
Despite the proliferation of mental health apps, many aren’t accessible for people with disabilities. The CEO of Toivoa plans to change that.
Alexandra Pecci • April 27, 2022 -
Getty Images
Mouse vs. machine: Using AI to solve the animal testing model in pharma
Quris is bringing its first drug tested preclinically using AI — rather than animal models — into human trials.
Michael Gibney • April 26, 2022 -
Permission granted by Ted Love.
For Global Blood Therapeutics, the connection to sickle cell disease runs deep
An underserved patient population is a guiding light for the company, which recently scored a new approval.
Robin Robinson • April 19, 2022 -
Permission granted by Entos/Steve Chen
With Lilly on board, Entos' medical chief champions genetic platform with 'unlimited' potential
Steve Chen is helping to lead Entos through an ‘inflection point’ in the development of its precision medicine delivery platform.
Alexandra Pecci • April 14, 2022 -
Permission granted by Alnylam/Yvonne Greenstreet
Seeing yourself at the top: Alnylam CEO on why representation matters
Dr. Yvonne Greenstreet became just the sixth woman in the world to head up a biopharma company with a market cap of more than $5 billion when she took on the role of CEO in January.
Alexandra Pecci • April 6, 2022 -
Permission granted by Alloy.
From media to menopause: Creating new spaces in women's telehealth
Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.
Alexandra Pecci • March 29, 2022 -
Permission granted by Russell Potterfield.
From angel to operator: The unlikely journey of Endevica Bio's CEO
Russell Potterfield is honing his new found passion for the space to guide Endevica into the clinic.
Jared Whitlock • March 9, 2022 -
Getty Images
Horizon’s VP of R&D on her ascent in biotech — and bringing other female scientists along for the ride
Elizabeth Thompson is guiding Horizon through new drug approvals while leading the way for young women in STEM.
Alexandra Pecci • March 8, 2022 -
Permission granted by Guadalupe Hayes-Mota
Guadalupe Hayes-Mota's 'recipe' for tackling pharma's supply chain issues
A quest to expand access to medical treatment globally led to a new career path when Guadalupe Hayes-Mota left his biotech leadership roles to start his own company.
Robin Robinson • Feb. 25, 2022
Previous
